Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF SAUDI ARABIA, TURKEY, AND EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 SAUDI ARABIA PRODUCTS AND SERVICES, LIFELINE CURVE
2.8 EGYPT PRODUCTS AND SERVICES, LIFELINE CURVE
2.9 TURKEY PRODUCTS AND SERVICES, LIFELINE CURVE
2.1 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.11 DBMR MARKET POSITION GRID
2.12 MARKET TESTING TYPE COVERAGE GRID
2.13 VENDOR SHARE ANALYSIS
2.14 SECONDARY SOURCES
2.15 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL'S MODEL
4.2 PORTER'S 5 FORCES
4.3 INDUSTRY INSIGHTS
5 REGULATORY GUIDELINES FOR IN VITRO DIAGNOSTICS QUALITY CONTROL
5.1 REGULATIONS IN SAUDI ARABIA
5.2 REGULATIONS IN TURKEY
5.3 REGULATIONS IN EGYPT
5.3.1 MEDICAL DEVICE REGISTRATION IN EGYPT, THE PROCESS IN BRIEF:
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING PREVALENCE OF CHRONIC DISEASES ACROSS SAUDI ARABIA, TURKEY, AND EGYPT
6.1.2 RISING ADOPTION OF QUALITY CONTROL SOLUTIONS IN LABORATORIES AND HOSPITALS
6.1.3 ADVANCEMENTS IN TECHNOLOGY LEADING TO THE DEVELOPMENT OF NEW AND ADVANCED DIAGNOSTIC PRODUCTS
6.1.4 RISING USE OF QUALITY CONTROL IN MOLECULAR DIAGNOSTICS
6.2 RESTRAINTS
6.2.1 HIGH COST RELATED TO QUALITY CONTROL AND MAINTENANCE OF IVD
6.2.2 STRINGENT REGULATIONS REGARDING IVD IN SAUDI ARABIA, TURKEY, AND EGYPT
6.3 OPPORTUNITIES
6.3.1 RISE IN STRATEGIC ACQUISITION AND PARTNERSHIP AMONG ORGANIZATIONS
6.3.2 RISING RESEARCH AND DEVELOPMENT ACTIVITIES
6.4 CHALLENGES
6.4.1 LACK OF INFRASTRUCTURE IN HEALTHCARE SERVICE
6.4.2 SHORTAGE OF SKILLED PERSONNEL FOR HANDLING QUALITY CONTROL OF IN VITRO DIAGNOSTIC DEVICES.
7 SAUDI ARABIA, TURKEY, AND EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCT AND SERVICES
7.1 OVERVIEW
7.2 QUALITY CONTROL PRODUCTS
7.2.1 SERUM/PLASMA-BASED CONTROL
7.2.2 WHOLE BLOOD-BASED CONTROLS
7.2.3 URINE-BASED CONTROLS
7.2.4 OTHER CONTROLS
7.2.5 INTERNAL QUALITY CONTROL
7.2.6 EXTERNAL QUALITY CONTROL
7.3 QUALITY CONTROL SERVICES
8 SAUDI ARABIA, TURKEY, AND EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 CLINICAL CHEMISTRY
8.3 IMMUNOCHEMISTRY
8.4 HEMATOLOGY
8.5 MOLECULAR DIAGNOSTICS
8.5.1 QUALITY CONTROL PRODUCTS
8.5.1.1 INTERNAL QUALITY CONTROL
8.5.1.2 EXTERNAL QUALITY CONTROL
8.5.2 QUALITY CONTROL SERVICES
8.6 COAGULATION/HEMOSTASIS
8.7 MICROBIOLOGY
8.8 OTHERS
9 SAUDI ARABIA, TURKEY, AND EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY SECTOR
9.1 OVERVIEW
9.2 CLINICAL
9.3 NON-CLINICAL
10 SAUDI ARABIA, TURKEY, AND EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER
10.1 OVERVIEW
10.2 CLINICAL LABORATORIES
10.3 ACADEMIC AND RESEARCH INSTITUTES
10.4 PHARMACEUTICAL INDUSTRY
10.5 BIOTECHNOLOGY INDUSTRY
10.6 BLOOD BANKS
10.7 OTHERS
11 SAUDI ARABIA, TURKEY, AND EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: SAUDI ARABIA
11.2 COMPANY SHARE ANALYSIS: EGYPT
11.3 COMPANY SHARE ANALYSIS: TURKEY
12 SWOT ANALYSIS
13 TURKEY IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, COMPANY PROFILES
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 PRODUCT PORTFOLIO
13.1.4 RECENT DEVELOPMENTS
13.2 SIEMENS HEALTHCARE GMBH
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 PRODUCT PORTFOLIO
13.2.4 RECENT DEVELOPMENT
13.3 BIO-RAD LABORATORIES, INC.
13.3.1 COMPANY SNAPSHOT
13.3.2 REVENUE ANALYSIS
13.3.3 PRODUCT PORTFOLIO
13.3.4 RECENT DEVELOPMENT
13.4 BECKMAN COULTER, INC.
13.4.1 COMPANY SNAPSHOT
13.4.2 PRODUCT PORTFOLIO
13.4.3 RECENT DEVELOPMENT
13.5 SYSMEX CORPORATION
13.5.1 COMPANY SNAPSHOT
13.5.2 REVENUE ANALYSIS
13.5.3 PRODUCT PORTFOLIO
13.5.4 RECENT DEVELOPMENT
13.6 AGAPPE DIAGNOSTICS LTD
13.6.1 COMPANY SNAPSHOT
13.6.2 PRODUCT PORTFOLIO
13.6.3 RECENT DEVELOPMENT
13.7 DIASORIN MOLECULAR LLC.
13.7.1 COMPANY SNAPSHOT
13.7.2 PRODUCT PORTFOLIO
13.7.3 RECENT DEVELOPMENT
13.8 RANDOX LABORATORIES LTD.
13.8.1 COMPANY SNAPSHOT
13.8.2 PRODUCT PORTFOLIO
13.8.3 RECENT DEVELOPMENT
13.9 SERA CARE
13.9.1 COMPANY SNAPSHOT
13.9.2 PRODUCT PORTFOLIO
13.9.3 RECENT DEVELOPMENT
13.1 SPECTRUM DIAGNOSTICS
13.10.1 COMPANY SNAPSHOT
13.10.2 PRODUCT PORTFOLIO
13.10.3 RECENT DEVELOPMENT
13.11 TECHNOPATH CLINICAL DIAGNOSTICS
13.11.1 COMPANY SNAPSHOT
13.11.2 PRODUCT PORTFOLIO
13.11.3 RECENT DEVELOPMENT
14 QUESTIONNAIRE
15 RELATED REPORTS
List of Figure
FIGURE 1 SAUDI ARABIA, TURKEY, AND EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET: SEGMENTATION
FIGURE 2 SAUDI ARABIA, TURKEY, AND EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET: DATA TRIANGULATION
FIGURE 3 SAUDI ARABIA, TURKEY, AND EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET: DROC ANALYSIS
FIGURE 4 SAUDI ARABIA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET: COUNTRY MARKET ANALYSIS
FIGURE 5 EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET: COUNTRY MARKET ANALYSIS
FIGURE 6 TURKEYS IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET: COUNTRY MARKET ANALYSIS
FIGURE 7 SAUDI ARABIA, TURKEY, AND EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 8 SAUDI ARABIA, TURKEY, AND EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 9 SAUDI ARABIA, TURKEY, AND EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET: DBMR MARKET POSITION GRID
FIGURE 10 SAUDI ARABIA, TURKEY, AND EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET: MARKET TESTING TYPE COVERAGE GRID
FIGURE 11 SAUDI ARABIA, TURKEY, AND EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET: VENDOR SHARE ANALYSIS
FIGURE 12 SAUDI ARABIA, TURKEY, AND EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET: SEGMENTATION
FIGURE 13 RISING PREVALENCE OF CHRONIC DISEASES ACROSS SAUDI ARABIA IS EXPECTED TO DRIVE THE SAUDI ARABIA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET IN THE FORECAST PERIOD
FIGURE 14 RISING ADOPTION OF QUALITY CONTROL SOLUTIONS IN LABORATORIES AND HOSPITALS IS EXPECTED TO DRIVE THE TURKEY IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET IN THE FORECAST PERIOD IN THE FORECAST PERIOD
FIGURE 15 ADVANCEMENTS IN TECHNOLOGY LEADING TO THE DEVELOPMENT OF NEW AND ADVANCED DIAGNOSTIC PRODUCTS ARE EXPECTED TO DRIVE THE EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET IN THE FORECAST PERIOD IN THE FORECAST PERIOD
FIGURE 16 THE PRODUCT AND SERVICES TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE SAUDI ARABIA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET IN 2023 & 2030
FIGURE 17 THE PRODUCT AND SERVICES TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE TURKEY IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET IN 2023 & 2030
FIGURE 18 THE PRODUCT AND SERVICES TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET IN 2023 & 2030
FIGURE 19 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF SAUDI ARABIA, TURKEY, AND EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET
FIGURE 20 SAUDI ARABIA, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCTS AND SERVICES, 2022
FIGURE 21 TURKEY, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCTS AND SERVICES, 2022
FIGURE 22 EGYPT, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCTS AND SERVICES, 2022
FIGURE 23 SAUDI ARABIA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCTS AND SERVICES, 2023-2030 (USD THOUSAND)
FIGURE 24 TURKEY IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCTS AND SERVICES, 2023-2030 (USD THOUSAND)
FIGURE 25 EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCTS AND SERVICES, 2023-2030 (USD THOUSAND)
FIGURE 26 SAUDI ARABIA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCTS AND SERVICES, CAGR (2023-2030)
FIGURE 27 TURKEY IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCTS AND SERVICES, CAGR (2023-2030)
FIGURE 28 EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCTS AND SERVICES, CAGR (2023-2030)
FIGURE 29 SAUDI ARABIA, TURKEY AND EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCTS AND SERVICES, LIFELINE CURVE
FIGURE 30 TURKEY IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCTS AND SERVICES, LIFELINE CURVE
FIGURE 31 EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCTS AND SERVICES, LIFELINE CURVE
FIGURE 32 SAUDI ARABIA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, 2022
FIGURE 33 TURKEY IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, 2022
FIGURE 34 EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, 2022
FIGURE 35 SAUDI ARABIA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, 2023-2030 (USD THOUSAND)
FIGURE 36 TURKEY IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, 2023-2030 (USD THOUSAND)
FIGURE 37 EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, 2023-2030 (USD THOUSAND)
FIGURE 38 SAUDI ARABIA, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, CAGR (2023-2030)
FIGURE 39 TURKEY, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, CAGR (2023-2030)
FIGURE 40 EGYPT, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, CAGR (2023-2030)
FIGURE 41 SAUDI ARABIA, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, LIFELINE CURVE
FIGURE 42 TURKEY, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, LIFELINE CURVE
FIGURE 43 EGYPT, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION, LIFELINE CURVE
FIGURE 44 SAUDI ARABIA, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY SECTOR, 2022
FIGURE 45 TURKEY, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY SECTOR, 2022
FIGURE 46 EGYPT, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY SECTOR, 2022
FIGURE 47 SAUDI ARABIA, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY SECTOR, 2023-2030 (USD THOUSAND)
FIGURE 48 TURKEY, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY SECTOR, 2023-2030 (USD THOUSAND)
FIGURE 49 EGYPT, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY SECTOR, 2023-2030 (USD THOUSAND)
FIGURE 50 SAUDI ARABIA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY SECTOR, CAGR (2023-2030)
FIGURE 51 TURKEY IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY SECTOR, CAGR (2023-2030)
FIGURE 52 EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY SECTOR, CAGR (2023-2030)
FIGURE 53 SAUDI ARABIA, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY SECTOR, LIFELINE CURVE
FIGURE 54 TURKEY IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY SECTOR, LIFELINE CURVE
FIGURE 55 EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY SECTOR, LIFELINE CURVE
FIGURE 56 SAUDI ARABIA, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, 2022
FIGURE 57 TURKEY IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, 2022
FIGURE 58 EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, 2022
FIGURE 59 SAUDI ARABIA, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, 2023-2030 (USD THOUSAND)
FIGURE 60 TURKEY, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, 2023-2030 (USD THOUSAND)
FIGURE 61 EGYPT, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, 2023-2030 (USD THOUSAND)
FIGURE 62 SAUDI ARABIA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, CAGR (2023-2030)
FIGURE 63 TURKEY IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, CAGR (2023-2030)
FIGURE 64 EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, CAGR (2023-2030)
FIGURE 65 SAUDI ARABIA, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, LIFELINE CURVE
FIGURE 66 TURKEY, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, LIFELINE CURVE
FIGURE 67 EGYPT, IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER, LIFELINE CURVE
FIGURE 68 SAUDI ARABIA IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET: COMPANY SHARE 2022 (%)
FIGURE 69 EGYPT IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET: COMPANY SHARE 2022 (%)
FIGURE 70 TURKEY IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET: COMPANY SHARE 2022 (%)
